Cypress Bioscience (CYPB +39%) and Forest Labs (FRX +7.5%) get FDA approval for Savella in...

|By:, SA News Editor

Cypress Bioscience (CYPB +39%) and Forest Labs (FRX +7.5%) get FDA approval for Savella in fibromyalgia treatment. Other stocks that could see an FDA bump: AMAG Pharma (AMAG), BioDelivery Sciences (BDSI), Momenta Pharma (MNTA). (more)